On Tuesday, health news site STAT reported that drug maker Eli Lilly and the Food and Drug Administration granted a 79-year-old access to retatrutide, a hotly anticipated treatment, under compassionate use, which allows patients with severe health issues to access experimental therapies
Arajo, L
Liver and kidney tissue damages were reported to affect neuronal cells and affect cognition
Add the people who have used a GLP-1 and come off it, and the share of shoppers whose habits have been reset at least once is much larger than the current-user number
doi: 10.1016/j.eprac.2020.09.001 41 BernardVYoungJBinartN
Obesity is a chronic disease that puts nearly 900 million adults worldwide at an increased risk of other complications such as type 2 diabetes, said Jeff Emmick, MD, PhD, SVP of product development at Lilly, in a statement